7 completed, 3 unknown, 2 terminated, 1 withdrawn. 13 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 13 | Completed 7, Unknown 3, Terminated 2, Withdrawn 1 |
Follow Personality Disorders: new trials by email Literature Review of Personality Disorders trials Research Report on Personality Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Role Of Sensitivity to neuroEndocrine Systems in Social Decisions Hydrocortisone, Yohimbine, Placebo - Borderline Personality Disorder | Phase 4 | Withdrawn | University of North Carolina, Chapel Hill | 2024-07-01 | 2024-06-05 | |
| Changes of Gas Values in Cord Blood Versus Time and Temperature Cord blood samples - Abnormal; Birth | Phase 4 | Unknown | Tel-Aviv Sourasky Medical Center | 1000 | 2016-06-01 | 2016-05-27 |
| Hormones and Decision Making testosterone propionate, 0.5% cholorbutanol, saline - Dyssocial Behavior | Phase 4 | Completed | University of Texas at Austin | 30 | 2015-03-01 | 2021-04-29 |
| Reduction of Cardiovascular Risk in Severe Mental Illness Lifestyle counseling - Severe Mental Illness, Schizophrenia | Phase 4 | Unknown | Consorci Hospitalari de Vic | 391 | 2010-08-01 | 2010-08-16 |
| Comparing Treatments for Self-Injury and Suicidal Behavior in People With Borderline Personality Disorder Fluoxetine, DBT, Citalopram - Borderline Personality Disorder, Suicide | Phase 4 | Completed | New York State Psychiatric Institute | 84 | 2009-03-01 | 2017-08-18 |
| Efficacy of Omega-3 Fatty Acids on Borderline Personality Disorder Omacor®, Placebo - Borderline Personality Disorder. | Phase 4 | Unknown | Hospital Universitari Vall d'Hebron Research Institute | 102 | 2009-02-01 | 2010-05-27 |
| Efficacy of a Triptan in the Treatment of Hostility and Aggression Among Convicts With a Psychiatric Treatment Order naratriptan, placebo - Psychotic Disorders, Antisocial Personality Disorder | Phase 4 | Terminated | UMC Utrecht | 8 | 2006-11-01 | 2015-01-26 |
| Study of Lamotrigine Treatment of Affective Instability in Borderline Personality Disorder Lamotrigine, Placebo - Borderline Personality Disorder | Phase 4 | Completed | Mclean Hospital | 28 | 2004-12-01 | 2008-03-12 |
| Effective Measurement of Risperidone Treatment Outcome for Persons With Borderline Personality Disorder risperidone - Borderline Personality Disorder | Phase 4 | Completed | University of Alabama at Birmingham | 20 | 2003-07-01 | 2021-06-10 |
| Treating Suicidal Behavior and Self-Mutilation in People With Borderline Personality Disorder Fluoxetine, Dialectical Behavior Therapy, Supportive psychotherapy - Borderline Personality Disorder | Phase 4 | Completed | New York State Psychiatric Institute | 91 | 2001-03-01 | 2024-01-05 |
| Multimodal Treatment Study of Children With Attention Deficit and Hyperactivity Disorder (MTA) Psychosocial treatment, Anti-ADHD medication, Assessment-and-Referral - Attention Deficit Disorder With Hyperactivity, Substance-related Disorders | Phase 4 | Completed | NYU Langone Health | 1998-09-01 | 2015-09-29 | |
| Effects of Comorbid Personality Disorder on the Treatment of Bipolar I Disorder Interpersonal Social Rhythm Therapy (IPSRT) - Bipolar I Disorder, Borderline Personality Disorder | Phase 4 | Completed | University of Pittsburgh | 13 | 1997-08-01 | 2013-06-25 |
| Pharmacology of Cognition in Schizotypal Personality Disorder Guanfacine, Placebo - Schizotypal Personality Disorder, Personality Disorders | Phase 4 | Terminated | Icahn School of Medicine at Mount Sinai | 29 | 1995-09-01 | 2017-02-10 |
Borderline Personality Disorder (7) · Antisocial Personality Disorder (4) · Psychotic Disorders (2) · Self-Injurious Behavior (2) · Suicide (2) · Attention Deficit Disorder with Hyperactivity (1) · Bipolar Disorder (1) · Disruptive, Impulse Control, and Conduct Disorders (1) · Medication Adherence (1) · Mental Disorders (1) · Mood Disorders (1) · Schizophrenia (1) · Schizotypal Personality Disorder (1) · Substance-Related Disorders (1)
Mental Disorders (12) · Behavior (3) · Behavioral Symptoms (2) · Schizophrenia Spectrum and Other Psychotic Disorders (2) · Attention Deficit and Disruptive Behavior Disorders (1) · Bipolar and Related Disorders (1) · Chemically-Induced Disorders (1) · Health Behavior (1) · Neurodevelopmental Disorders (1) · Patient Acceptance of Health Care (1) · Patient Compliance (1) · Treatment Adherence and Compliance (1)
Fluoxetine (2) · Citalopram (1) · Dialectical Behavior Therapy (1) · Guanfacine (1) · Hydrocortisone (1) · Lamotrigine (1) · Omacor (1) · Risperidone (1) · Sodium Chloride (1) · Sugars (1) · Testosterone Propionate (1) · Yohimbine (1) · naratriptan (1)
New York State Psychiatric Institute (2) · Consorci Hospitalari de Vic (1) · Hospital Universitari Vall d'Hebron Research Institute (1) · Icahn School of Medicine at Mount Sinai (1) · Mclean Hospital (1) · NYU Langone Health (1) · Tel-Aviv Sourasky Medical Center (1) · UMC Utrecht (1) · University of Alabama at Birmingham (1) · University of North Carolina, Chapel Hill (1) · University of Pittsburgh (1) · University of Texas at Austin (1)
United States (8) · Spain (2) · Netherlands (1)
Adriano van der Loo, MD (1) · Barbara H. Stanley, PhD (1) · Barbara Stanley, PhD (1) · Berend Olivier, PhD (1) · C. Keith Conners (1) · Celia T. Huston, PhD (1) · D. Bradford Reich, M.D. (1) · Ellen Frank (1) · Frank Koerselman, MD, PhD (1) · Henk Nijman, PhD (1) · Howard B. Abikoff, PhD (1) · James M. Swanson, PhD (1) · Larry J. Siever, MD (1) · Laurence L. Greenhill, MD (1) · Michael N Hallquist, PhD (1)
PMID 33884617, PMID 36375174, PMID 10591283, PMID 10591284, PMID 10637676, PMID 10637677, PMID 11104313, PMID 11104315, PMID 11104317, PMID 11211363, PMID 11211364, PMID 11211365, PMID 11211366, PMID 11211367, PMID 11294072, PMID 12014781, PMID 12108764, PMID 12795577, PMID 12880507, PMID 14998110, PMID 15060225, PMID 15677282, PMID 16135621, PMID 16671928, PMID 16881772, PMID 16950221, PMID 17053977, PMID 17667478, PMID 17667479, PMID 17667480, PMID 17667481, PMID 17710545, PMID 18573923, PMID 18573924, PMID 19307987, PMID 19318991, PMID 20390813, PMID 20883582, PMID 23452682, PMID 23834228, PMID 25524791, PMID 28913744, PMID 29050505, PMID 30388029, PMID 31120201, PMID 31421233, PMID 31445873, PMID 32368793, PMID 34384227, PMID 39431909
R01MH061017 (2), R01MH056140 (1), U01MH050453 (1)